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Abstract 
Vascular Nox-derived ROS and ER stress have been implicated in hypertension. However 
relationships between these processes is unclear. We hypothesized that Nox isoforms localize 
in a sub-cellular compartment-specific manner, contributing to oxidative and ER stress, which 
influence the oxidative proteome and vascular function in hypertension. Nox 
compartmentalization (cell fractionation), O2
- (lucigenin), H2O2 (amplex red), reversible 
protein oxidation (sulfenylation), irreversible protein oxidation (protein tyrosine phosphatase 
(PTP), peroxiredoxin oxidation) and ER stress (PERK, IRE1α, phosphorylation/oxidation) 
were studied in SHR VSMCs. VSMC proliferation was measured by FACS and vascular 
reactivity assessed in SHRSP arteries by myography. Noxs were downregulated by siRNA 
and pharmacologically. In SHR, Noxs were localized in specific sub-cellular regions: Nox1 in 
plasma-membrane and Nox4 in ER. In SHR, oxidative stress was associated with increased 
protein sulfenylation and hyperoxidation of PTPs and peroxiredoxins. Inhibition of Nox1 
(NoxA1ds), Nox1/4 (GKT 137831) and ER stress (4-PBA/Tudca), normalized SHR vascular 
ROS generation. GKT137831 reduced IRE1α sulfenylation and XBP1 splicing in SHR. 
Increased VSMC proliferation in SHR was normalized by GKT137831,4-PBA and 
STF083010, (IRE1-XBP1 disruptor). Hypercontractility in SHRSP was attenuated by 4-PBA. 
We demonstrate that protein hyperoxidation in hypertension is associated with oxidative and 
ER stress through upregulation of plasmalemmal-Nox1 and ER-Nox4. The IRE1-XBP1 
pathway of the ER stress response is regulated by Nox4/ROS and plays a role in the 
hyperproliferative VSMC phenotype in SHR. Our study highlights the importance of Nox 
sub-cellular compartmentalization and interplay between cytoplasmic ROS and ER stress 
response, which contribute to the VSMC oxidative proteome and vascular dysfunction in 
hypertension.  
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Non-standard abbreviations 
4-PBA   4-Phenylbutyric acid 
Ang II   angiotensin II 
BiP    immunoglobulin heavy-chain-binding protein 
CHOP   CCAAT-enhancer-binding protein homologous protein 
Cys   cysteine 
DiGE   differential gel electrophoresis 
DTT   dithiothreitol 
eIF2a   eukaryotic initiation factor 2a 
ER   endoplasmic reticulum 
Grp78   glucose-regulated protein 78 
H2O2   hydrogen peroxide 
HDAC3  histone deacetylase 3 
IRE1α   inositol-requiring enzyme 1 
NEM   N-ethyl-maleimide 
Nox   NADPH oxidases 
Nrf2   nuclear factor erythroid 2-related factor 2  
O2
-   superoxide 
PCNA   Proliferating Cell Nuclear Antigen  
PERK   protein kinase RNA-like endoplasmic reticulum kinase 
PP1   protein phosphatase 1  
Prx   peroxiredoxin 
PTP   protein tyrosine phosphatase 
PTP1B   protein tyrosine phosphatase 1B 
ROS   reactive oxygen species 
SHP-2   Src-homology 2 domain (SH2)-containing PTP  
SHR   spontaneously hypertensive rat 
SHRSP  stroke-prone spontaneously hypertensive rat 
UPR   unfolded protein response 
VSMC   vascular smooth muscle cells 
WKY   wistar-kyoto rat 
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Introduction 
NADPH oxidase (Nox)-derived reactive oxygen species (ROS) are important signaling 
molecules in vascular smooth muscle cells (VSMC) with pleiotropic actions participating in 
diverse processes such as cell growth, migration, inflammation, fibrosis and contraction1. 
Mechanisms regulating these distinct functions are unclear but may relate to specific Nox 
isoforms, sub-cellular compartmentalization of Nox/ROS, post-translational oxidative 
modification of signaling proteins and interaction with stress response processes, such as 
endoplasmic reticulum (ER) stress2, 3.  
In hypertension, increased vascular Nox expression and activity are associated with oxidative 
stress and aberrant redox signaling leading to dysregulated endothelial cell and VSMC 
function and consequent vascular injury4, 5. Nox-derived ROS is a tightly controlled process 
involving multiple Nox isoforms (Nox 1-5 and Duox 1-2), of which Nox1, Nox2 and Nox4 
are functionally present in the rodent vasculature6. Once generated, ROS influence signalling 
molecules through post-translational oxidative modification of proteins7. Oxidation can be 
reversible or irreversible, with the oxidation status influencing cellular functional responses. 
Major forms of reversible oxidation include modification of cysteine to sulfenic acid 
(sulfenylation, SOH), reaction with glutathione (glutathionylation, GSH), and formation of 
disulfide bonds among others8, 9. Reversible cysteine oxidation is key to redox signalling 
providing a mechanism of redox switch for protein function and cell function. In VSMCs, 
oxidation of protein tyrosine phosphatases (PTPs) is especially important because oxidation 
inactivates the enzyme, leading to increased phosphorylation of downstream kinases critically 
involved in the regulation of vascular function10. In pathological conditions, high 
concentrations of ROS can result in irreversible oxidation, such as protein carbonylation, 
(modification of amino acid side chains to carbonyl derivatives) and formation of sulfinic and 
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sulfonic acid on cysteine residues (SO2H, SO3H), leading to protein damage, degradation and 
cell death11. 
Oxidative stress can also influence the function of organelles such as the ER, a major site of 
protein synthesis, lipid biosynthesis and Ca2+ storage and signalling12. Hence alterations in the 
ER can have an impact on cell function and fate. The ER responds to accumulation of 
misfolded proteins by activating the unfolded protein response (UPR). This complex 
signalling network can either restore ER homeostasis and promote cell survival or apoptosis13. 
ROS are produced in the ER as byproducts of protein folding and certain ER stress conditions 
can increase ROS production in the ER3. ER stress has been implicated in experimental 
hypertension14, 15. However, the relationship between oxidative stress and ER stress and the 
interaction between these processes in vascular dysfunction in hypertension is unknown. 
We hypothesize that compartmentalisation of Nox-derived ROS contributes to oxidative and 
ER stress through oxidation of proteins that influence vascular function in hypertension. To 
address this we examined in VSMCs the subcellular compartmentalization and ROS-
generating function  of Nox isoforms and investigated how oxidative stress impacts the 
oxidative proteome focusing on reversible and irreversible oxido-reductive modifications and 
explored the role of ER stress in these processes. Further studies investigating the potential 
functional significance of ROS/ER stress in isolated vessels were assessed by myography. 
Methods 
The authors declare that all supporting data are available within the article and its online 
supplementary files. 
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Isolation and culture of VSMCs. Primary VSMCs were isolated from mesenteric arteries 
from WKY and SHR by enzymatic digestion, as we described16.  
Cell Fractionation. Plasma membrane proteins and nuclear/ER fraction were obtained using 
a plasma membrane isolation and nuclear extraction kit, respectively. ER and mitochondria 
were obtained by differential centrifugation.  
ROS measurements. ROS levels were measured in VSMCs that had been pre-treated with 
NoxA1ds (Nox1 inhibitor), GKT137831 (Nox1/4 inhibitor) and 4-Phenylbutyric acid (4-
PBA) (ER stress inhibitor) and stimulated with Ang II. Lucigenin-enhanced 
chemiluminescence was used to detect NADPH-dependent superoxide anion (O2
-) production 
in VSMC16. Hydrogen peroxide (H2O2) levels were assessed by Amplex Red Hydrogen 
Peroxide/Peroxidase Assay Kit. 
Immunoblotting. VSMC proteins were resolved by SDS-PAGE, transferred onto a 
nitrocellulose membrane and probed with primary antibodies. Secondary fluorescence-
coupled antibodies were visualized by an infrared laser scanner. Immunoimages were 
quantified using the software Image Studio™ Lite.   
Assessment of protein sulfenylation. To assess sulfenylation, we used two different probes 
that specifically bind sulfenic acid groups in proteins; BCN-E-BCN17 and biotin-tagged 
dimedone-based probe (DCP-Bio)18.  
Affinity capture of sulfenylated proteins. VSMCs were labelled with DCP-Bio1 and 
submitted to the same procedures described for sulfenylation assessment. Affinity capture of 
sulfenylated proteins was performed using high capacity streptavidin beads.  
Determination of irreversible PTP and Peroxiredoxin (Prx) oxidation. VSMCs were 
lysed and analysed by immunoblotting using specific antibodies, which recognize the 
hyperoxidized catalytic centre (-SO3H) on PTPs and Prx.  
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Proliferation assay. The fluorescein-based dye 5,6-carboxyfluorescein diacetate 
succinimidyl ester (CFSE) was used to assess VSMC proliferation in cells treated with 
NoxA1ds, GKT137831, 4-PBA and STF-083010 (disruptor of Ire1-XBP1 pathway). Flow 
cytometry analysis with Ex/Em 492⁄517 filters was performed using the FACS CANTO II 
system.  
Vascular function assessed by wire myography. Segments of mesenteric arteries from 
WKY and SHRSP were mounted on a wire myograph. Contraction was assessed with KCl. 
Endothelial integrity was verified by relaxation induced by acetylcholine (Ach)  in vessels 
pre-contracted with phenylephrine (PE). Endothelium-dependent relaxation was assessed by 
concentration-response curves to ACh and noradrenaline (NA). In some experiments, vessels 
were pre-treated with 4-PBA. 
Statistical Analysis 
All results are mean±SEM. For comparisons between two groups, Student’s t-test was used. 
For multiple comparisons one-way analysis of variance followed by Bonferroni’s post-test 
was conducted, as appropriate. p<0.05 was considered significant. 
Results 
Increased protein sulfenylation and irreversible oxidation in VSMCs from hypertensive 
rats.  
A major mechanism whereby ROS influence cell function is through post-translational 
oxidative modification of downstream protein targets. Of the numerous redox-sensitive 
processes, modification of cysteine residues within proteins are particularly important in the 
context of oxidative stress, such as in hypertension. Cysteine thiols can be oxidized initially to 
sulfenic acid (Cys-SOH). The resultant cysteine S-sulfenylation, can be further oxidized into 
reversible (disulfides, glutathionylated species) or irreversible (sulfinic (–SO2H) or sulfonic 
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acid (–SO3H)) oxidative modifications, depending on the ROS bioavailability. We 
investigated whether increased ROS bioavailability in hypertension is associated with 
increased protein sulfenylation and irreversible cysteine oxidation in proteins. 
Using two different probes, a biotin-tagged dimedone-based probe (DCP-Bio) and a 
cyclooctyne probe (BCN-E-BCN),  that binds specifically to sulfenylated proteins we showed 
an increase in protein sulfenylation in SHR cells (Figures 1A and 1B). Irreversible protein 
oxidation levels of Prx (Prx-SO3) and PTP (–SO2H and –SO3H), which translates into 
deactivation of these enzymes, was higher in VSMCs from hypertensive rats (Figures 1C and 
1D). Such differences suggest that the increased ROS levels in SHR cells are favouring 
irreversible oxidative modifications.  
Nox1 and Nox4 are involved in ROS generation and irreversible protein oxidation in 
hypertension. 
As NADPH oxidases are recognized as the major enzymatic source of ROS in vascular cells, 
we investigated the role of Nox isoforms in ROS generation and protein oxidation. Nox1, 
Nox2 and Nox4 are present in total cell homogenates in VSMCs from normotensive and 
hypertensive groups. Expression of Nox1 and Nox4 was greater in VSMCs from hypertensive 
versus normotensive rats (Supp Figure S1). Therefore, we investigated the role of Nox1 and 
Nox4 in ROS generation and oxidative modification of proteins. Both, the selective Nox1 
inhibitor NoxA1ds, as well as the Nox1/4 inhibitor GKT137831, decreased basal O2
- levels in 
the hypertensive group (Figure 2A). Basal H2O2 generation was significantly reduced by 
Nox1/4 inhibition in SHR cells. (Figure 2B). Basal levels were unaffected by Nox inhibitors 
in WKY. The scrambled peptide control for NoxA1ds had no effect on ROS generation. In 
addition, Nox1 and Nox4 downregulation with siRNA decreased basal ROS levels in SHR 
cells in both lucigenin and amplex red assay (Supp Figure S2). These findings suggest that in 
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SHR, Nox1 and Nox4 are constitutively active in resting conditions and are responsible for 
increased basal ROS generation in VSMCs in hypertensive rats. 
Ang II increased O2
-and H2O2 generation in WKY cells, an effect that was blocked by 
NoxA1ds (Figures 2A and B). In SHR cells, NoxA1ds and GKT137831 inhibited Ang II-
induced O2
- production (Figure 2A). H2O2 generation was not significantly altered by Ang II 
in SHR VSMCs (Figure2B). Together these data indicate that Ang II, a pro-hypertensive 
factor, increases ROS generation in WKY cells through Nox1-sensitive processes, similar to 
findings observed in SHR in basal conditions. Ang II also increased O2
- generation in SHR 
VSMCs, an effect likely involving Nox1 and Nox4.  
Next, we assessed the role of Nox1 and Nox4 in irreversible protein oxidation. NoxA1ds and 
GKT137831 significantly decreased oxidation of PTPs and Prx in SHR VSMCs (Figure 2C 
and D, respectively). Inhibition of both Nox1 and Nox4 with GKT137831 had no additional 
effect on irreversible oxidation levels.  
Nox isoforms are expressed in an organelle-specific manner. 
To better characterize redox-signaling in VSMCs and to evaluate whether Nox/ROS 
regulation is compartment-specific and differentially regulated in hypertension, we 
investigated the subcellular localization of Nox isoforms. Expression of Nox1, Nox2 and 
Nox4 was assessed by immunoblotting after cell fractionation (Figure 3). All Nox isoforms 
were detected in plasma membrane, nuclear/ER fraction and in isolated ER in both strains. 
Housekeeping proteins used for cell membrane was Na/K ATPase, for ER was calreticulin, 
and HDAC3 for the nuclear/ER fraction. Expression of Nox1 was significantly increased in 
plasma membrane and nuclear/ER fraction of SHR compared to WKY cells (Figures 3A and 
3B). On the other hand, Nox4 levels were significantly increased only in the ER of VSMCs 
from SHR rats (Figure 3F). Nox2 levels were detected in all fraction, however no differences 
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were found between WKY and SHR (Supp Figure S3). Noxs were not detected in isolated 
mitochondria. However, we observed a decrease in basal ROS levels in SHR cells in the 
presence of mitoTEMPO19, an antioxidant targeted to mitochondria (Supp Figure S4). 
These findings indicate that Noxs are expressed in subcellular compartments, especially ER 
and nucleus. This is a highly regulated process, because not all organelles in which ROS are 
generated possess Noxs, as indicated by the absence of Nox1, 2 and 4 in isolated 
mitochondria. In addition, Nox isoforms can affect different protein targets by different 
subcellular locations: Nox1 in the plasma membrane and nucleus and Nox4 in the ER. The 
ER is a site of protein synthesis and a platform of stress signaling pathways that may be 
particularly important in oxidative stress in hypertension and was further investigated in our 
studies. 
ER stress plays a role in increased basal ROS levels in SHR. 
Based on our findings of increased Nox4 content in the ER in hypertension, we probed the 
potential interaction between Nox, ROS and ER and the possibility that Nox4-derived ROS in 
hypertension may influence ER function and ER stress. This is relevant because 
phosphorylation of the UPR mediators PERK (protein kinase RNA-like endoplasmic 
reticulum kinase) and IRE1α (inositol-requiring enzyme 1α), as well as expression of the 
chaperone BiP (immunoglobulin heavy-chain-binding protein) involved in the ER stress 
response was increased in SHR VSMCs compared with WKY cells (Supp Figure S5), 
indicating vascular ER stress in hypertension. 
To investigate if ER stress is associated with vascular oxidative stress, cells were treated with 
the chemical chaperone 4-PBA known to decrease ER stress levels. As shown in figures 4A 
and 4B, basal levels of O2
- and H2O2 were lowered by 4-PBA in SHR cells. In Ang II-treated 
cells, ROS levels were not significantly reduced by 4-PBA. In addition, tauroursodeoxycholic 
11 
 
acid  (Tudca), another ER stress inhibitor, decreased basal levels of ROS in SHR cells (Supp 
Figure S6).  
Only expression of Nox4 was attenuated by 4-PBA treatment in SHR VSMCs, with no effect 
observed in Nox1 expression (Figure 4C and 4D). These data suggest that in SHR VSMCs, 
Nox4 is involved in ER stress induced ROS generation. 
Nox-dependent ROS is involved in ER stress. 
Following our observation of a relationship between ER stress and Nox4-derived ROS in 
SHR, we next investigated if Noxs are involved in activation of the ER stress response. Nox-
derived-ROS through oxidation of cysteine thiols could inactivate PTPs altering 
phosphorylation of the UPR sensors IRE1α and PERK. To assess this, cells were treated with 
inhibitors of Nox1 and Nox4. Inhibition of Nox1 significantly decreased phosphorylation of 
PERK. A similar effect was observed with inhibition of both Nox1 and Nox4 (Figure 5A). 
However, phosphorylation of IRE1α was not influenced by any of the Nox inhibitors (Figure 
5B). siRNA downregulation of Nox1 or Nox4 resulted in decreased levels of phosphorylated 
PERK and IRE1 α, suggesting involvement of Nox-derived ROS in the activation of the UPR 
(Supp Figure S7).  
The UPR sensors IRE1α and PERK have critical cysteine residues in their structures that 
could be potential ROS targets. Using the byotinylated probe DCP-Bio1 to trap sulfenylated 
proteins and performing affinity capture assay using streptavidin beads, we were able to pull 
down and identify sulfenylated proteins in cells from WKY and SHR rats (Figure 5C-F). 
Biotinylated thioredoxin (Trx) from E. coli was added to the samples before affinity capture 
and used as elution and loading control. Our results demonstrated that IRE1α and PERK were 
more oxidized in SHR VSMCs compared with WKY. The Nox1/4 inhibitor reduced oxidation 
(sulfenylation) of IRE1α, however no effect was observed in PERK oxidation (Figure 5C and 
12 
 
5D). Other potential ER targets are the chaperone BiP and the phosphatase PTP1B. Both 
proteins were also more oxidized in SHR cells, however Nox inhibition failed to decrease 
oxidation levels of BiP and PTP1B (Figure 5E and 5F). These results reveal different roles for 
Nox1 and Nox4 in the activation of ER stress response. Nox4 seems to be involved 
specifically on IRE1α oxidation, with no effects on phosphorylation of this protein. On the 
other hand, both Nox1 and Nox4 are involved in phosphorylation of PERK without affecting 
its oxidation. 
Nox4 and ER stress are involved in increased VSMC proliferation in hypertension. 
Next we investigated the effects of oxidation on IRE1downstream signalling and cellular 
function. One of the downstream targets of IRE1 is the transcription factor X-box binding 
protein 1 (XBP1). Through its RNase activity,  activation of IRE1 promotes XBP1 alternative 
splicing and generation of its active form sXBP1 (spliced XBP1), which we measured in our 
experiemnatl models.  Expression of sXBP1 was assessed by western blot in VSMCs treated 
with NoxA1ds, GKT137831 and 4-PBA for 24h. As shown in Figure 6A, sXBP1 expression 
is increased in SHR in basal conditions compared with cells from WKY rats. Nox1/4 and ER 
stress inhibitors significantly decreased sXBP1 expression in SHR, while Nox1 inhibitor had 
no effect.   
The IRE1-sXBP1 arm of the ER stress response is involved in prosurvival signalling 
pathways. Therefore we  investigated the functional role of Nox isoforms and ER stress, on 
VSMC proliferation. Expression of PCNA (Proliferating Cell Nuclear Antigen) as a 
molecular readout of cell proliferation was assessed by western blot. In basal conditions 
PCNA expression was increased in SHR rats, this phenomena was inhibited by Nox1/4 and 
ER stress inhibitors (Supp Figure S8). Furthermore, using the CSFE proliferation assay we 
demonstrated that SHR cells are more proliferative than cells from WKY rats (Figure 6B and 
6C). Nox1/4 inhibitor (GKT137831) and the ER stress inhibitor (4-PBA) normalized SHR 
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VSMC proliferation. In addition, disruption of the IRE1-sXBP1 pathway using the compound 
STF083010, also decreased proliferation in SHR VSMCs, supporting a role for this arm of the 
ER stress response in the hyperproliferative phenotype of VSMC from SHR rats. Additional 
experiments using Nox1 siRNA, Nox4 siRNA and the ER stress inhibitor , Tudca, showed a 
role for Nox1 in basal growth conditions, while Nox4 and ER stress were involved in SHR 
proliferation (Supp Fig S9). 
ER stress is involved in vascular dysfunction in hypertensive rats 
To further investigate the functional impact of redox signaling and ER stress, vascular 
reactivity was evaluated in isolated mesenteric arteries of WKY and SHRSP rats. SHRSP 
arteries are especially hyperreactive and accordingly were studied here as a robust model to 
examine vascular function. Arteries from hypertensive rats showed significantly increased 
contraction in response to noradrenaline and decreased vascular relaxation to acetylcholine 
compared to normotensive rats (Supp Figure S10). Treatment with 4-PBA significantly 
reduced vascular contraction and improved vascular relaxation in the SHRSP group, 
suggesting a role for redox-regulated ER stress in vascular function. 
Discussion 
While extensive evidence indicates that Nox-derived ROS generation and vascular oxidative 
stress are important elements in the pathophysiology of hypertension1, 2, 4, 5, mechanisms 
linking these phenomena still remain elusive. Here we examined the role of Nox isoforms and 
ER stress response in these processes and demonstrate that in VSMCs from hypertensive rats: 
i) cysteine oxidation in proteins is increased, ii) Nox1 and Nox4, which localize primarily in 
the plasma membrane and ER respectively, are responsible for increased basal ROS 
generation; iii) Nox1 is associated with irreversible protein oxidation and phosphorylation of 
the UPR sensor PERK, whereas Nox4 is involved in a feedforward relationship with ER 
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stress response and oxidation of IRE1α, and iv) Nox4-induced hyperoxidation and ER stress 
promote vascular hyperproliferation hyperreactivity. Our findings identify interplay between 
oxidative stress and ER stress response as a novel molecular mechanism underlying protein 
hyperoxidation and vascular dysfunction in hypertension. This process involves differential 
upstream modulation of ER stress proteins, with PERK being Nox1-regulated and IRE1 
Nox4-regulated. Such highly controlled systems may relate, at least in part, to the distinct 
subcellular compartmentalization of Nox isoforms in VSMCs in hypertension (Supp Figure 
11).  
Oxidative modifications of cysteine residues within proteins are key components of redox 
signaling to modulate protein function. The first step in Cys oxidation is formation of sulfenic 
acid (Cys-SOH), or protein sulfenylation. Due to the unstable nature of Cys-SOH we used a 
direct approach to trap sulfenic acid in proteins. Dimedone-based probes, such as DCP-Bio1, 
have been successfuly used to detect protein sulfenylation in various biological samples18, 20, 
21. However, a limitation of dimedone-based probes are poor cell permeability, slow rates of 
reaction and may detect sulfenylamides in addition to sulfenic acid22, 23. To overcome these 
limitations we used a cyclooctyne probe (BCN-E-BCN), which is cell membrane permeable, 
that reacts with sulfenic acid with higher constant rates than other sulfenylation probes17. 
Using both probes, we demonstrated that general protein sulfenylation was increased in 
hypertension, suggesting an active oxidation process in hypertensive VSMCs. 
If exposed to high levels of ROS, further oxidation of cysteine S-sulfenylation can occur 
leading to formation of sulfinic (–SO2H) or sulfonic acid (–SO3H), irreversible types of 
oxidation. Of the protein groups that are particularly susceptible to oxidation are PTPs and 
Prxs. PTPs are important modulators of growth factor- induced signalling10. Irreversible PTP 
oxidation can result in sustained kinase activity, enhancing growth factor signalling. Our 
findings showing increased irreversible oxidation of PTPs in VSMCs from hypertensive rats 
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are in line with our previous studies that Ang II –induced oxidation of the phosphatase SHP-2 
is increased in hypertension and is associated with enhanced Ang II-dependent AKT 
signalling24.  
Prx, a thiol-dependent peroxide-eliminating enzyme, was also hyperoxidised in SHR. Under 
physiological conditions, Prx catalyzes the reduction of H2O2 and acts as an anti-oxidant, 
through reversible Cys oxidation. However in pathological conditions associated with 
oxidative stress, hyperoxidation of Prxs results in a switch to a redox sensor and chaperone 
molecule involved in cell signalling25. Prx2 knock-out mice showed higher levels of hydrogen 
peroxide, increased activation of PDGFR and PDGF-induced cell proliferation and 
migration26. This is of pathophysiological significance because irreversible protein oxidation 
causes aberrant cell signalling. formation of protein aggregates, disruption of proteolytic 
pathways, deregulated cell homeostasis and impaired function11, processes that likely 
contribute to vascular injury in hypertension.  
Noxs, as major enzymatic sources of ROS in the vasculature, play an important role in 
regulating oxidation of downstream protein targets as we demonstrated with Nox1/4 
inhibitors, which normalized ROS production and protein oxidation. Nox-derived ROS 
production is tightly controlled, and regulatory mechanisms may involve isoform specificity 
and compartmentalization27-29. We demonstrated that in VSMCs from hypertensive rats and in 
VSMCs from WKY stimulated with Ang II, a pro-hypertensive peptide, generation of O2
- and 
H2O2 was increased, processes associated with upregulation of Nox1 and Nox4 in a 
compartment-specific manner. In SHR VSMCs expression of Nox1 was increased in the 
plasma membrane and nuclear/ER fractions while expression of Nox4 was only increased in 
the ER fraction. These findings suggest specific roles for different Nox isoforms in 
hypertension, and highlight a potentially important role for the ER.  
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Given the observed plasmalemmal localization of Nox1, we speculated that Nox1-derived 
ROS is involved mainly in protein oxidation in the cell membrane and cytosol, rather than the 
ER. In support of this, we demonstrated a role for Nox1 in oxidation of PTPs and Prxs but not 
in ER-resident proteins. Although PERK oxidation was not influenced by Nox1, post 
translation phosphorylation of PERK and IRE1α was Nox1-ROS-sensitive. The mechanisms 
involved could be related to altered phosphorylation and dephosphorylation of upstream 
kinases and phosphatases or an indirect effect of oxidative stress. These changes may reflect a 
protective mechanism of the cell, because phosphorylation of PERK has been suggested to be 
an alternative pathway for activation of the antioxidant Nrf230. However, in VSMC from 
hypertensive rats this mechanism may be dysregulated, as we previously demonstrated31.  
Nox4 is constitutively activated and produces primarily H2O2. Unlike previous studies 
demonstrating an association between Nox4 and mitochondria32, we did not find localization 
of Nox4 in mitochondria. However, Nox4 was closely associated with the ER, with increased 
expression in SHR VSMCs. The functional significance of Nox4-ER may highlight cross-talk 
between oxidative stress and ER stress as previously suggested33, 34. ER stress, which is 
redox-sensitive, is triggered by altered ER function and activation of the UPR, leading to 
abnormal cell growth, apoptosis and inflammation13. ER stress also promotes oxidative stress, 
suggesting that ROS production is both upstream and downstream of UPR targets. Our 
findings support this feed-forward system, because ER stress inhibition with 2 different 
agents, 4-PBA and Tudca, reduced H2O2 production, while Nox4 inhibition and silencing  in 
turn attenuated activity of UPR signalling molecules. Activators of ER stress 7-
ketocholesterol35 and tunicamycin36 have been shown to stimulate Nox4 activity .   
The functional significance of Nox4-ER interaction awaits clarification, but Nox4 association 
with ER stress induces activation of Ras/ERK signalling promoting autophagy and cell 
survival36. On the other hand, in cardiac ischemia-reperfusion injury and acute kidney injury, 
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Nox4 inhibited the phosphatase PP1 resulting in increased phosphorylation of eIF2a and 
enhanced cell survival37. In our study, we showed that Nox4 specifically oxidizes the ER 
membrane-associated sensor IRE1α but no other ER resident proteins such as PERK, BiP or 
PTP1B, suggesting that Nox-induced oxidation of ER stress proteins is Nox isoform-specific 
and highly regulated.  
Oxidation of proteins can have different outcomes depending on the state of protein oxidation. 
For example Cys oxidation of PTPs leads to its inactivation, while sulfenylation of Cys 
residues in EGFR enhance its kinase activity38. Many proteins undergo both phosphorylation 
and oxidation, with some studies suggesting that the oxidative modification primes the protein 
for activation upon phosphorylation21. We demonstrated that PERK is both phosphorylated 
and sulfenylated in VSMCs  from hypertensive rats, likely influencing the activation of this 
ER stress-related kinase.  
IRE1 is composed of an endoribonuclease and a kinase domain. Upon activation of the 
endoribonuclease domain, IRE1 cleaves XBP1 resulting in the spliced active transcription 
factor sXBP1 involved in ER homeostasis and cell survival. IRE1 kinase domain is involved 
in activation of ASK1-JNK pathway resulting in apoptosis39. Sulfenylation of IRE1 in yeast 
has been reported to block activation of the classic UPR signalling pathway and initiates the 
p38/Nrf2 antioxidant response promoting cell survival and growth40. Therefore, we 
investigated if IRE1 oxidation could favour activation of XBP1 and cell survival in SHR 
cells. We demonstrated that in SHR sXBP1 expression is increased and this effect is reversed 
by GKT137831 and 4-PBA,  but not by NoxA1ds, suggesting a role for Nox4 in modulation 
of IRE1 signalling. Furthermore  SHR proliferation was reduced by GKT137831, 4-PBA and 
STF 083010, a disruptor of IRE1-XBP1 pathway , supporting  a role for IRE1-XBP1 in the 
hyperproliferative phenotype in SHR cells. Altogether, Nox4-induced oxidation of IRE1α 
may be a counterregulatory mechanism against oxidative stress. In addition BiP sulfenylation 
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is involved in ER protection in oxidative conditions, since oxidized BiP inhibits its ATPase 
activity, while enhancing the binding to unfolded proteins, increasing cell survival and 
proliferation41. Therefore, increased oxidative stress and consequent oxidation of BiP and 
IRE1 could result in dysregulation of these mechanisms contributing to the hyperproliferative 
phenotype we observed in SHR VSMCs.  
Our studies also demonstrate an important role for redox-regulated ER stress response in the 
control of vascular function. Reducing ER stress with the chemical chaperone 4-PBA 
attenuated hypercontractility and improved vasodilatory responses in vessels from 
hypertensive rats. Supporting our findings, acute induction of ER stress impaired 
vasorelaxation in isolated mesenteric arteries in a Nox-dependent manner15. In addition, 4-
PBA protected against renal injury in hypertension and diabetes and had beneficial effects in 
experimental models of pulmonary hypertension42-44. Taken together there seems to be 
important interplay between oxidative and ER stress, that influence vascular function in 
hypertension. 
Perspectives 
We demonstrate that in hypertension, vascular redox signalling is related to Nox isoform 
specificity, distinct subcellular localization of Nox1 and Nox4 and differential post-
translational oxidative modification of proteins. Increased ROS generation in hypertension 
was associated with an altered redox profile characterized by protein hyperoxidation, 
primarily due to increased irreversible oxidation of proteins, including PTPs, Prx and ER 
stress-related proteins PERK and IRE1. Our data identify novel Nox/ROS-regulated 
mechanisms involving the IRE1-XBP1 pathway of the ER stress response in the VSMC 
proliferative phenotype in SHR, and highlight the important interplay between oxidative 
stress and redox-regulated ER response in vascular dysfunction in hypertension These 
findings advance the understanding of vascular redox biology in hypertension. 
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Novelty and Significance 
What is New? 
 Nox isoforms are upregulated in a compartment-specific manner in SHR VSMCs  
 Plasma membrane-associated Nox1 and ER-associated  Nox4 may contribute to 
differential vascular redox events in hypertension 
 Oxidative stress is associated with protein hyperoxidation and ER stress in 
hypertension 
What is relevant? 
 The vascular oxidative proteome in hypertension is characterised by increased 
reversible and irreversible protein oxidation. 
 Complex interplay between oxidative stress and the ER stress response control VSMC 
proliferation and vascular dysfunction in hypertension 
Summary 
 We  provide insights into novel molecular pathways linking Nox 
compartmentalization, post-translational oxidative modification of proteins and ER 
stress, that play a role in the vascular phenotype in hypertension. 
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Figure Legends 
Figure 1. Protein oxidation is increased in VSMCs from hypertensive rats (SHR). 
Reversible cysteine oxidation (sulfenylation) was assessed by biotinylated probes DCP-Bio1 
(A) and BCN-E-BCN (B). Irreversible protein oxidation was assessed by western blot of 
peroxiredoxin hyperoxidation (C) and oxidized PTPs (D). α-tubulin was used as loading 
control. Data represent mean±SE of 3-12 independent experiments. *p<0.05 SHR vs WKY.  
Figure 2. Nox1 and Nox4 are involved in ROS generation and protein oxidation in 
hypertension. Superoxide anion and hydrogen peroxide were measured by lucigenin-derived 
chemiluminescence (A) and amplex red (B) in VSMCs stimulated with angiotensin II (Ang II, 
100nmol/L) for 5 minutes in the presence of NoxA1ds (N1) (10µmol/L, Nox1 inhibitor), 
NoxA1ds scrambled control (Scb) or GKT137831 (GKT) (10µmol/L, Nox1/4 inhibitor). 
Irreversible protein oxidation was assessed by western blot of PTP oxidation (C) and 
peroxiredoxin hyperoxidation (D) in the presence of Nox inhibitors. Results are expressed as 
mean±SEM of 6-10 separate experiments.*p<0.05 vs WKY control (Ctl), +p<0.05 and 
++p<0.01 vs respective Ctl, #p<0.05 vs SHR Ctl and &p<0.05 vs SHR N1.   
Figure 3. Subcellular localization of Nox1 and Nox4 in VSMCs from WKY and SHR 
rats. Expression of Nox1 and Nox4 in isolated plasma membrane (A and D), 
nuclear/endoplasmic reticulum fraction (B and E) and isolated endoplasmic reticulum (C and 
F). Results are expressed as mean±SEM of 4 separate experiments and were normalized by 
Na/K ATPase (plasma membrane marker), HDAC3 (Histone deacetylase 3; nuclear marker) 
or Calreticulin (ER marker).*p<0.05 vs WKY. 
Figure 4. ER stress is involved in ROS generation in SHR VSMCs. ROS generation was 
measured by chemiluminescence (A) and amplex red (B) in the presence of the chemical 
chaperone 4-PBA (1mmol/L, 24h). Nox1 (C) and Nox4 (D) expression in the presence of 4-
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PBA was assessed by western blot. Protein quantification was normalized by α- tubulin. 
Results are expressed as mean±SEM of 6-9 separate experiments. *p<0.05 vs WKY Ctl, and  
+p<0.05 vs SHR Ctl. 
Figure 5. Differential activation of UPR activators by Nox1 and Nox4. (A) 
Phosphorylation of PERK and (B) IRE1α in the presence of NoxA1ds (N1) (10µmol/L) and 
GKT137831 (GKT) (10µmol/L) was assessed by western blot. Sulfenylated PERK (C), IRE1 
α (D), BiP (E) and PTP1B (F) were pulled down by affinity capture using the biotin-tagged 
dimedone-based probe (DCP-Bio) in cells treated with NoxA1ds or GKT137831. Protein 
quantification was normalized by total PERK, α- tubulin or biotinylated thioredoxin from 
E.coli (Trx) for the sulfenylation assay. Results are expressed as mean±SEM of 4-7 separate 
experiments. *p<0.05 vs WKY Ctl and +p<0.05 vs SHR Ctl. 
Figure 6. ER stress is involved in increased proliferation in VSMCs from SHR. (A) 
Spliced XBP1 expression (sXBP1) was detected by western blot in VSMCs from WKY and 
SHR in the presence of Nox inhibitors (NoxA1ds or GKT137831) and ER stress inhibitors (4-
PBA). Protein quantification was normalized by α- tubulin. Proliferation was assessed using 
the CSFE assay (B and C) in the presence of Nox inhibitors, ER stress inhibitor and IRE1 
inhibitor STF-083010 (STF). Results are expressed as mean±SEM of 5 separate experiments. 
*p<0.05 vs WKY Ctl and and +p<0.05 vs SHR Ctl. 
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